Mismatch Repair Participates in an Error-Free Repair of Psoralen Crosslinks in Human Cells.

Qi Wu,Laura A. Christensen,Kelsey Gray,Karen M. Vásquez

IF: 11.2

2004-01-01

Cancer Research

Abstract:2278 Psoralen is a bifunctional crosslinking agent that can form DNA interstrand crosslinks (ICLs) following exposure to UVA irradiation. ICLs present a formidable block to DNA metabolism and must be repaired for cell survival. Crosslinking agents are both beneficial and detrimental to human health, as they are used in the treatment of human disease, yet they are also known to induce mutagenesis, which may lead to tumorigenesis. In bacteria, the repair of ICLs is performed primarily by nucleotide excision repair (NER) and homologous recombination (HR). However little is known about the repair of ICLs in mammalian cells. We and others have demonstrated previously that NER is involved in an error-prone repair of triplex-directed psoralen ICLs. Recently it has been reported that mismatch repair (MMR) proteins are involved in the removal of psoralen ICLs in human cell extracts. Here we show for the first time, that MMR is involved in an error-free repair of triplex-directed ICLs in human cells. Because NER is involved in an error-prone repair of triplex-directed ICLs, we hypothesized that MMR may be involved in an error-free repair of these lesions. To test this hypothesis, we used psoralen-conjugated triplex-forming oligonucleotides to target ICLs to a specific site in a mutation reporter plasmid. Binding assays demonstrated that human MSH2-3 specifically bound the psoralen ICLs with high affinity. We performed DNA repair assays to compare the processing of the lesion in MMR-deficient and -proficient human cell extracts. The DNA repair synthesis level was greatly reduced in the MMR-deficient extracts, suggesting that MMR plays a critical role in the processing of ICLs. To determine the nature of the MMR repair, we subjected ICL-damaged plasmids to a mutagenesis assay in MMR-deficient and -proficient human cell lines. The mutation frequencies were similarly high in both MMR-deficient and -proficient human cells. These results indicate that the MMR proteins do not participate in the error-prone repair of ICLs. Taken together, our findings suggest that human MMR proteins can recognize triplex-directed psoralen ICLs and participate in an error-free repair of this complex lesion in human cells. Thus it may be possible to sensitize a cell to repair a triplex-directed psoralen ICL in an error-free fashion by regulating the function of these proteins.